Migraine firm enters clinic on back of million-dollar investment
![Rehaler's device to treat migraines goes by the company's name, and uses a person's own carbon dioxide to combat migraine attacks | Photo: Rehaler / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14555508.ece/ALTERNATES/schema-16_9/doc7ngkkxt8hc2vowb0mx8.jpg)
Medtech company Rehaler has received a capital injection of DKK 12m (USD 1.5m), which ensures one year of ongoing operations, CEO Troels Johansen tells MedWatch.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.